Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider has learned.

Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

It also accused 23andMe of neglecting to notify certain users that data from people with Chinese or Ashkenazi Jewish heritage ...

23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...

The biggest stories of the day delivered to your inbox.

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and ...

Holding announced the launch of Discover23, a new research offering enabling authorized collaborators to securely access the power ...

(JTA) — The genetic testing company 23andMe is facing a class action lawsuit over its security practices after hackers stole and published data about 1 million people with Jewish ancestry.

Two of the most popular brands are Ancestry and 23andMe. To learn more, we outlined the pros, cons and factors to consider. However, since this comparison was first published, 23andMe has ...

23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations ...